IONS
Ionis and Ono Pharmaceutical announce global license agreement for sapablursen for polycythemia vera
Tuesday, March 11, 2025 1 min read
Key Takeaway: Ionis and Ono Pharmaceutical announce global license agreement for sapablursen for polycythemia vera
Full Press Release Details
Ionis and Ono Pharmaceutical announce global license agreement for sapablursen for polycythemia vera.